CSL

Carlisle Companies Incorporated

61
Fundamentals56/ 100
Valuation45/ 100
Upside potential59/ 100
Risk potential17/ 100

CSL's fundamentals are mixed: it turned 14% of its revenue into free cash flow, but its operating margin fell 1 points to 19%. At 22x earnings, it's trading above its usual 20x. Analysts expect strong earnings growth.

CSL Fundamentals

MetricStatus
Healthy
Healthy
Stable
Stable

CSL's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.

CSL PE Valuation

CHEAPFAIREXPENSIVE9.6x19x29x38x
CHEAPFAIREXPENSIVE9.6x19x29x38x
LevelPEPriceVs current
Cheap15x$258-34%
Forward17x$393—
Fair20x$351-11%
Current22x$393—
Expensive26x$459+17%

Historical ranges are pointers, not guarantees.

CSL's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.

CSL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for CSL, with profitability improving.

CSL Risk to reward

ScenarioChangePrice
Upside+26%$492.81
Downside-17%$324.07

Calculated from the latest close: $392.59 on Nov 12.

CSL's one-year upside scenario is somewhat larger than its downside: +26% against −17%.

CSL Earnings Per Share

Q4 2023: $15.24Q1 2024: $17.25Q2 2024: $28.30Q3 2024: $28.26Q4 2024: $27.82Q1 2025: $27.05Q2 2025: $18.09Q3 2025: $17.82Q4 2025: $17.12Q1 2026: $17.02Q2 2026: $17.44Q3 2026: $17.70Forward: $23.69
Q4 2023: $15.24Q1 2024: $17.25Q2 2024: $28.30Q3 2024: $28.26Q4 2024: $27.82Q1 2025: $27.05Q2 2025: $18.09Q3 2025: $17.82Q4 2025: $17.12Q1 2026: $17.02Q2 2026: $17.44Q3 2026: $17.70Forward: $23.69
QuarterTTM EPSYoY
Forward$23.69+34%
Q3 2026$17.70-0.7%
Q2 2026$17.44-3.6%
Q1 2026$17.02-37%
Q4 2025$17.12-38%
Q3 2025$17.82-37%
Q2 2025$18.09-36%
Q1 2025$27.05+57%
Q4 2024$27.82+83%

CSL's earnings per share have fallen from their peak: $17.70 over the past year, against $28.30 in mid-2024.

CSL Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.1BQ2 2024: $1.5BQ3 2024: $1.3BQ4 2024: $1.1BQ1 2025: $1.1BQ2 2025: $1.4BQ3 2025: $1.3BQ4 2025: $1.1BQ1 2026: $1.1BQ2 2026: $1.6BQ3 2026: $1.5B
Q4 2023: $1.1BQ1 2024: $1.1BQ2 2024: $1.5BQ3 2024: $1.3BQ4 2024: $1.1BQ1 2025: $1.1BQ2 2025: $1.4BQ3 2025: $1.3BQ4 2025: $1.1BQ1 2026: $1.1BQ2 2026: $1.6BQ3 2026: $1.5B
QuarterRevenueYoY
Q3 2026$1.5B+8.6%
Q2 2026$1.6B+8.3%
Q1 2026$1.1B-4%
Q4 2025$1.1B+0.4%
Q3 2025$1.3B+1%
Q2 2025$1.4B-0.1%
Q1 2025$1.1B-0.1%
Q4 2024$1.1B-0.4%

CSL's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.6% from the same quarter a year ago.

CSL Free Cash Flow

Q4 2023: $353MQ1 2024: $131MQ2 2024: $159MQ3 2024: $294MQ4 2024: $334MQ1 2025: −$27MQ2 2025: $258MQ3 2025: $393MQ4 2025: $346MQ1 2026: −$73MQ2 2026: $200MQ3 2026: $277M
Q4 2023: $353MQ1 2024: $131MQ2 2024: $159MQ3 2024: $294MQ4 2024: $334MQ1 2025: −$27MQ2 2025: $258MQ3 2025: $393MQ4 2025: $346MQ1 2026: −$73MQ2 2026: $200MQ3 2026: $277M
QuarterFree cash flowYoY
Q3 2026$277.3M-30%
Q2 2026$200.1M-23%
Q1 2026-$73M-$45.8M
Q4 2025$346.1M+3.6%
Q3 2025$393.4M+34%
Q2 2025$258.3M+63%
Q1 2025-$27.2M-121%
Q4 2024$334M-5.4%

CSL still generates free cash flow, though less than at its 2023 peak: $751M over the past year.

CSL Total Shares

Q4 2023: 50MQ1 2024: 48MQ2 2024: 48MQ3 2024: 47MQ4 2024: 47MQ1 2025: 45MQ2 2025: 43MQ3 2025: 43MQ4 2025: 43MQ1 2026: 41MQ2 2026: 41MQ3 2026: 40M
Q4 2023: 50MQ1 2024: 48MQ2 2024: 48MQ3 2024: 47MQ4 2024: 47MQ1 2025: 45MQ2 2025: 43MQ3 2025: 43MQ4 2025: 43MQ1 2026: 41MQ2 2026: 41MQ3 2026: 40M
PeriodChange %Net change
Quarterly-2.2%-900K shares
1 year-7.7%-3.3M shares
3 years-21%-10.5M shares
5 years-25%-13.4M shares
Available history-31%-17.9M shares

CSL has 40M diluted shares, down 7.7% from a year ago, with $1.1B in buybacks over the past year.

CSL Net Leverage

Q4 2023: 1.4xQ1 2024: 1.4xQ2 2024: 0.4xQ3 2024: 0.6xQ4 2024: 0.9xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.5xQ4 2025: 1.5xQ1 2026: 1.8xQ2 2026: 1.8xQ3 2026: 1.9x
Q4 2023: 1.4xQ1 2024: 1.4xQ2 2024: 0.4xQ3 2024: 0.6xQ4 2024: 0.9xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.5xQ4 2025: 1.5xQ1 2026: 1.8xQ2 2026: 1.8xQ3 2026: 1.9x
QuarterNet LeverageStatus
Q3 20261.9xHealthy
Q2 20261.8xHealthy
Q1 20261.8xHealthy
Q4 20251.5xHealthy
Q3 20251.5xHealthy
Q2 20251.5xHealthy
Q1 20251.3xHealthy
Q4 20240.9xVery low

CSL's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.4 years a year ago.

CSL Weekly Momentum

MetricValueStatus
RSI61.2Neutral
Stochastic76.1Neutral

CSL's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).

CSL PE vs Industrials Sector

MetricCSLSector medianRelative
PE22x24x7.7% below
PE %67589 pts above

CSL is trading at 22x earnings, in line with the Industrials sector's median of 24x.

CSL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$350.012% above
20 week MA$351.112% above
50 week MA$352.111% above
100 week MA$357.010% above
200 week MA$341.915% above

CSL is in an uptrend: it's above all five of its weekly moving averages, and 15% above its 200-week average.

CSL Yearly ROI

YearStart priceEnd priceROI
2020$163.0$157.4-3.5%
2021$157.4$240.8+53%
2022$240.8$237.9-1.2%
2023$237.9$312.4+31%
2024$312.4$372.0+19%
2025$372.0$330.3-11%
2026 YTD$330.3$392.6+19%

CSL has finished lower in three of the last six years. It's up 19% so far in 2026.

Give your agent the market.

Get API key